AzTrials
AzTrials

Acute Respiratory InsufficiencyWEANINGNCT02939963

Ventilation Strategies During Spontaneous Breathing Trial

A study testing ATC then pressure support 7 cm H2O PEP 4 cm H2O and Pressure support 7 cm H2O PEP 4 cm H2O then ATC in people with Acute Respiratory Insufficiency, run by Hospices Civils de Lyon at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Patients who are intubated and mechanically ventilated for acute respiratory failure in the Intensive Care Unit (ICU) are at some point eligible for weaning. The common way to wean them from mechanical ventilation is to screen criteria for feasibility and, if present, to test feasibility by performing spontaneous… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Acute Respiratory Insufficiency
What is being tested?
ATC then pressure support 7 cm H2O PEP 4 cm H2O and Pressure support 7 cm H2O PEP 4 cm H2O then ATC
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteFrance
Study dates
23 Aug 2017to 5 Oct 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • age 18 years or more
  • intubated and mechanically ventilated for at least 24 consecutive hours
  • staying in the medical ICU at the Croix Rousse Hospital, Lyon, France
  • pressure support ventilation 10-15 cm H2O, total respiratory rate 25-35 breaths/min, expired tidal volume 6-8 ml/kg predicted body weight
  • meeting criteria for spontaneous breathing trial (able to answer simple questions, no ongoing intravenous sedation, norepinephrine ≤ 1 mg/H, dobutamine ≤ 20 mg/h, fraction of inspired oxygen (FIO2 ≤ 50%), PEP ≤ 5 cm H2O, respiratory rate ≤ 35 breaths/min, saturation in oxygen (SpO2) ≥88%)
  • under Dräger Evita XL ou V500 ICU ventilator
  • agreement to participate from the patient or next of kin

Who cannot join

  • Chronic respiratory failure under long term home oxygen therapy and/or non invasive ventilation before ICU admission
  • Tracheotomy
  • nasogastric tube contra-indicated
  • thoracic tube in place
  • no agreement to participate
  • under justice protection
Show all 10Show fewer
  • deprived of freedom
  • pregnant or breastfeeding
  • not affiliated to social insurance
  • involved into another study that may interfere with present study

Trial locations and contacts

1 site in 1 country.

France1 site
  • Hôpital de la Croix Rousse

    Lyon, 69004

Other trials in France

About this study

Official title: Comparison of Two Ventilatory Modes During Spontaneous Breathing Trial in Intubated Patients

Patients who are intubated and mechanically ventilated for acute respiratory failure in the Intensive Care Unit (ICU) are at some point eligible for weaning. The common way to wean them from mechanical ventilation is to screen criteria for feasibility and, if present, to test feasibility by performing spontaneous breathing trial. This latter can be done either by setting a low pressure support level (expected to compensate the airflow resistance due to endotracheal tube) or by allowing the patient to breathe spontaneously through the tube without any support from the ventilator. Combination of low pressure assistance strategy (7 cm H2O) and positive expiratory pressure (PEP) of 4 cm H2O is the strategy used in our unit. Such a low pressure support level should actually result in a real assistance and, hence this is not the real spontaneous breathing capacity that is tested. Some ICU ventilators offer the option of compensating for the airflow resistance due to endotracheal tube, automatic tube compensation (ATC). Therefore, investigators aimed at comparing in patients ready to wean the usual procedure in our ICU and the ATC mode. In the ATC arm, the patients are breathing spontaneously through the endotracheal tube and are connected to the ventilator set at inspiratory pressure support of 0 cm H2O, PEP 4 cm H2O and ATC on.

Two parallel arms depending on the order of allocation of each mode: pressure support 7 cm H2O + PEP 4 cm H2O then ATC or the opposite. The primary endpoint is the power of the work of breathing. The hypothesis is that the power of the work of breathing is greater in ATC than in the usual procedure, and hence this latter is a real ventilator support.

Being tested
ATC then pressure support 7 cm H2O PEP 4 cm H2O, Pressure support 7 cm H2O PEP 4 cm H2O then ATC
Keywords
weaning, mechanical ventilation, work of breathing, automatic tube compensation, pressure support ventilation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ATC then pressure support 7 cm H2O PEP 4 cm H2OProcedure or surgery

    spontaneous breathing through endotracheal tube with no ventilator support except for ATC, the patient is connected to the ventilator with pressure support 0 cm H2O and PEP 4 cm H2O during 30 minutes then 30 minutes of basal pressure support then 30 minutes with pressure support 7 cm H2O PEP 4 cm H2O

  • Pressure support 7 cm H2O PEP 4 cm H2O then ATCProcedure or surgery

    30 minutes with pressure support 7 cm H2O PEP 4 cm H2O then 30 minutes of basal pressure support then 30 minutes with spontaneous breathing through endotracheal tube with no ventilator support except for ATC, the patient is connected to the ventilator with pressure support 0 cm H2O and PEP 4 cm H2O

Study groups in NCT02939963
Study groupRoleWhat they receive
ATC then pressure support 7 cm H2O PEP 4 cm H2OExperimentalspontaneous breathing through endotracheal tube with no ventilator support except for ATC
Receives: Procedure: ATC then pressure support 7 cm H2O PEP 4 cm H2O
pressure support 7 cm H2O PEP 4 cm H2O then ATCExperimentalventilator is set to pressure support ventilation mode at set pressure 7 cm H2O above PEEP level of 4 cm H2O
Receives: Procedure: Pressure support 7 cm H2O PEP 4 cm H2O then ATC

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. the power of work of breathing

    the work of breathing is measured from the area subtended by the esophageal pressure - lung volume relationship. The power of work of breathing is obtained by multiplying work of breathing by the respiratory frequency and expressed in Joules/min

    Measured: 30 minutes after onset the ventilator strategy

Secondary outcomes (6)
  1. Respiratory rate

    the respiratory rate is measured from the airflow tracing

    Measured: 30 minutes

  2. tidal volume

    integration of airflow over time during expiration

    Measured: 30 minutes

  3. intrinsic PEP

    deflection in esophageal pressure up to the first zero flow

    Measured: 30 minutes

  4. occlusion pressure at 100 ms

    measured from the airway pressure at the first 100 ms after airway occlusion

    Measured: 30 minutes

  5. work of breathing per liter

    work of breathing normalized for 1 liter tidal volume

    Measured: 30 minutes

  6. Distribution of pulmonary ventilation

    distribution of pulmonary ventilation will be measured by the Pulmovista system

    Measured: 30 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Oct 2016 (estimated)
  2. Study start23 Aug 2017
  3. Primary completion5 Oct 2018
  4. Study completion5 Oct 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Masking
None (open label)
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02939963
Sponsor's protocol ID
69HCL16_0411
Other IDs
2016-A01172-49
Acronym
WEANING
Status last verified
Sep 2025
First submitted
19 Oct 2016
Last updated
18 Sep 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Guerin C, Terzi N, Mezidi M, Baboi L, Chebib N, Yonis H, Argaud L, Heunks L, Louis B. Low-pressure support vs automatic tube compensation during spontaneous breathing trial for weaning. Ann Intensive Care. 2019 Dec 13;9(1):137. doi: 10.1186/s13613-019-0611-y.

    PubMed 31836913

Questions about this trial

What is this clinical trial studying?

A study testing ATC then pressure support 7 cm H2O PEP 4 cm H2O and Pressure support 7 cm H2O PEP 4 cm H2O then ATC in people with Acute Respiratory Insufficiency, run by Hospices Civils de Lyon at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

the power of work of breathing (time frame: 30 minutes after onset the ventilator strategy). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02939963, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Sep 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in